{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:36:25Z","timestamp":1789094185985,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s13300-024-01637-z","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T10:03:17Z","timestamp":1724752997000},"page":"2249-2261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Insights into Knowledge and Attitudes About Autoantibody Screening from People Affected by Type\u00a01 Diabetes: A Brief Report"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4656-3031","authenticated-orcid":false,"given":"Caitlin S.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilee M.","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"issue":"2","key":"1637_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type\u00a01 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10(2):98\u2013115.\u00a0https:\/\/doi.org\/10.34172\/hpp.2020.18","journal-title":"Health Promot Perspect"},{"issue":"6","key":"1637_CR2","doi-asserted-by":"publisher","first-page":"2333794X1987039","DOI":"10.1177\/2333794x19870394","volume":"1","author":"SR Mencher","year":"2019","unstructured":"Mencher SR, Frank G, Fishbein J. Diabetic ketoacidosis at onset of type\u00a01 diabetes: rates and risk factors today to 15\u00a0years ago. Global Pediatr Health. 2019;1(6):2333794X19870394. https:\/\/doi.org\/10.1177\/2333794x19870394","journal-title":"Global Pediatr Health"},{"issue":"11","key":"1637_CR3","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.2337\/dc21-0770","volume":"44","author":"RD Leslie","year":"2021","unstructured":"Leslie RD, Evans-Molina C, Freund-Brown J, et al. Adult-onset type\u00a01 diabetes: current understanding and challenges. Diabetes Care. 2021;44(11):2449\u201356.\u00a0https:\/\/doi.org\/10.2337\/dc21-0770","journal-title":"Diabetes Care"},{"issue":"6","key":"1637_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2337\/dci23-0013","volume":"46","author":"MJ Redondo","year":"2023","unstructured":"Redondo MJ, Van Raalte DH. Age ain\u2019t nothing but a number \u2026 or is it? Diabetes Care. 2023;46(6):1135\u20136.\u00a0https:\/\/doi.org\/10.2337\/dci23-0013","journal-title":"Diabetes Care"},{"issue":"12","key":"1637_CR5","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s00125-023-06004-4","volume":"66","author":"NJ Thomas","year":"2023","unstructured":"Thomas NJ, Jones AG. The challenges of identifying and studying type\u00a01 diabetes in adults. Diabetologia. 2023;66(12):2200\u201312.\u00a0https:\/\/doi.org\/10.1007\/s00125-023-06004-4","journal-title":"Diabetologia"},{"issue":"9","key":"1637_CR6","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.2337\/dc13-0425","volume":"36","author":"JM Sosenko","year":"2013","unstructured":"Sosenko JM, Skyler JS, Palmer JP, et al. The prediction of type\u00a01 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type\u00a01 diabetic patients. Diabetes Care. 2013;36(9):2615\u201320.\u00a0https:\/\/doi.org\/10.2337\/dc13-0425","journal-title":"Diabetes Care"},{"key":"1637_CR7","doi-asserted-by":"publisher","unstructured":"Eason RJ, Thomas NJ, Hill AV, Knight BA, Carr A, T. Hattersley A, et al. Routine islet autoantibody testing in clinically diagnosed adult-onset type 1 diabetes can help identify misclassification and the possibility of successful insulin cessation. 2022. https:\/\/doi.org\/10.2337\/figshare.21120535","DOI":"10.2337\/figshare.21120535"},{"issue":"Suppl_1","key":"1637_CR8","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-s002","volume":"47","author":"NA ElSayed","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee, ElSayed NA, Aleppo G, et al. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care. 2024;47(Suppl_1):S20\u201342. https:\/\/doi.org\/10.2337\/dc24-s002","journal-title":"Diabetes Care"},{"issue":"11","key":"1637_CR9","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.2337\/dci21-0043","volume":"44","author":"RIG Holt","year":"2021","unstructured":"Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type\u00a01 diabetes in adults. A consensus report by the american diabetes association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589\u2013625.\u00a0https:\/\/doi.org\/10.2337\/dci21-0043","journal-title":"Diabetes Care"},{"issue":"10","key":"1637_CR10","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type\u00a01 diabetes: a scientific statement of JDRF, the endocrine society, and the american diabetes association. Diabetes Care. 2015;38(10):1964\u201374.\u00a0https:\/\/doi.org\/10.2337\/dc15-1419","journal-title":"Diabetes Care"},{"key":"1637_CR11","doi-asserted-by":"publisher","DOI":"10.12788\/jfp.0223","author":"S Peters","year":"2021","unstructured":"Peters S. Screening for autoantibodies in type\u00a01 diabetes a call to action. J Family Pract. 2021. https:\/\/doi.org\/10.12788\/jfp.0223.","journal-title":"J Family Pract"},{"issue":"4","key":"1637_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.2337\/dbi20-0054","volume":"71","author":"EK Sims","year":"2022","unstructured":"Sims EK, Besser REJ, Dayan C, et al. Screening for type\u00a01 diabetes in the general population: a status report and perspective. Diabetes. 2022;71(4):610\u201323.\u00a0https:\/\/doi.org\/10.2337\/dbi20-0054","journal-title":"Diabetes"},{"issue":"5","key":"1637_CR13","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2337\/db20-1112","volume":"70","author":"CJ Greenbaum","year":"2021","unstructured":"Greenbaum CJ. A key to T1D prevention: screening and monitoring relatives as part of clinical care. Diabetes. 2021;70(5):1029\u201337.\u00a0https:\/\/doi.org\/10.2337\/db20-1112","journal-title":"Diabetes"},{"issue":"7","key":"1637_CR14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1089\/dia.2015.0316","volume":"18","author":"AK Steck","year":"2016","unstructured":"Steck AK, Fouts A, Miao D, et al. ECL-IAA and ECL-GADA can identify high-risk single autoantibody-positive relatives in the TrialNet pathway to prevention study. Diabetes Technol Ther. 2016;18(7):410\u20134.\u00a0https:\/\/doi.org\/10.1089\/dia.2015.0316","journal-title":"Diabetes Technol Ther"},{"key":"1637_CR15","doi-asserted-by":"publisher","DOI":"10.12788\/jfp.0618","author":"S Edelman","year":"2023","unstructured":"Edelman S. Early intervention by family physicians to delay type\u00a01 diabetes. J Fam Prac. 2023. https:\/\/doi.org\/10.12788\/jfp.0618.","journal-title":"J Fam Prac"},{"issue":"4","key":"1637_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s2352-4642(22)00350-9","volume":"7","author":"M Ghalwash","year":"2023","unstructured":"Ghalwash M, Anand V, Lou O, et al. Islet autoantibody screening in at-risk adolescents to predict type\u00a01 diabetes until young adulthood: a prospective cohort study. Lancet Child Adolesc Health. 2023;7(4):261\u20138.\u00a0https:\/\/doi.org\/10.1016\/s2352-4642(22)00350-9","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"1637_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13052-023-01438-3","volume":"49","author":"V Cherubini","year":"2023","unstructured":"Cherubini V, Chiarelli F. Autoantibody test for type\u00a01 diabetes in children: are there reasons to implement a screening program in the general population? A statement endorsed by the Italian Society for Paediatric Endocrinology and Diabetes (SIEDP-ISPED) and the Italian Society of Paediatrics (SIP). Ital J Pediatr. 2023;49(1):87.\u00a0https:\/\/doi.org\/10.1186\/s13052-023-01438-3","journal-title":"Ital J Pediatr"},{"issue":"6","key":"1637_CR18","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2337\/dc16-0181","volume":"42","author":"JP Krischer","year":"2019","unstructured":"Krischer JP, Liu X, Vehik K, et al. Predicting islet cell autoimmunity and type\u00a01 diabetes: an 8-year TEDDY study progress report. Diabetes Care. 2019;42(6):1051\u201360.\u00a0https:\/\/doi.org\/10.2337\/dc16-0181","journal-title":"Diabetes Care"},{"key":"1637_CR19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae158","author":"M Sooy","year":"2024","unstructured":"Sooy M, Pyle L, Alonso GT, et al. Lower prevalence of diabetic ketoacidosis at diagnosis in research participants monitored for hyperglycemia. J Clin Endocrinol Metabol. 2024.  https:\/\/doi.org\/10.1210\/clinem\/dgae158.","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"1637_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ecl.2023.09.008","volume":"53","author":"P Gomez","year":"2024","unstructured":"Gomez P, Sanchez J. Type\u00a01 diabetes screening and diagnosis. Endocrinol Metab Clin North Am. 2024;53(1):17\u201326. https:\/\/doi.org\/10.1016\/j.ecl.2023.09.008","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl_1","key":"1637_CR21","doi-asserted-by":"publisher","first-page":"668-P","DOI":"10.2337\/db23-634-p","volume":"72","author":"M Peter","year":"2023","unstructured":"Peter M, Chapman KSM, Dunne JL, Kelly CS, Wolf W. 668-P: exploring attitudes toward autoantibody screening in people living with T1D, caregivers, and first-degree relatives. Diabetes. 2023;72(Suppl_1):668-P.\u00a0https:\/\/doi.org\/10.2337\/db23-634-p","journal-title":"Diabetes"},{"key":"1637_CR22","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria; 2016. https:\/\/www.R-project.org\/"},{"key":"1637_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2024\/9927027","volume":"2024","author":"LM Quinn","year":"2024","unstructured":"Quinn LM, Narendran P, Bhavra K, et al. Developing a general population screening programme for paediatric type\u00a01 diabetes: evidence from a qualitative study of the perspectives and attitudes of parents. Pediatr Diabetes. 2024;2024:1\u201310. https:\/\/doi.org\/10.1155\/2024\/9927027.","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"1637_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S2213-8587(22)00391-6","volume":"11","author":"O Kordonouri","year":"2023","unstructured":"Kordonouri O, Reschke F, Danne T. Teplizumab approval for type\u00a01 diabetes in the USA. Lancet Diabetes Endocrinol. 2023;11(2):77\u20138.\u00a0https:\/\/doi.org\/10.1016\/s2213-8587(22)00391-6","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"1637_CR25","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00125-023-05953-0","volume":"66","author":"S Hummel","year":"2023","unstructured":"Hummel S, Carl J, Friedl N, et al. Children diagnosed with presymptomatic type\u00a01 diabetes through public health screening have milder diabetes at clinical manifestation. Diabetologia. 2023;66(9):1633\u201342.\u00a0https:\/\/doi.org\/10.1007\/s00125-023-05953-0","journal-title":"Diabetologia"},{"issue":"5","key":"1637_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011144","volume":"6","author":"J Raab","year":"2016","unstructured":"Raab J, Haupt F, Scholz M, et al. Capillary blood islet autoantibody screening for identifying pre-type\u00a01 diabetes in the general population: design and initial results of the Fr1da study. BMJ Open. 2016;6(5):e011144.\u00a0https:\/\/doi.org\/10.1136\/bmjopen-2016-011144","journal-title":"BMJ Open"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01637-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-024-01637-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01637-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T21:13:36Z","timestamp":1726780416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-024-01637-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1637"],"URL":"https:\/\/doi.org\/10.1007\/s13300-024-01637-z","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Caitlin S. Kelly, Wendy A. Wolf, Emilee M. Cornelius, Megan E. Peter, and Katherine S. Chapman are employees of T1D Exchange. Jessica L. Dunne was employed at Janssen R&D during data collection and is now employed at Sanofi US. The authors have no other conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study received an exemption waiver from WCG-IRB. This study was performed in accordance with the Helsinki Declaration of 1964 and its amendments. All participants in this study provided electronic informed consent prior to participation. No identifiable information from participants has been used in this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}